Emerging Pathways in COPD: Targeting Inflammation for A Tailored Treatment Approach - Episode 8
Evolving Treatment Landscape in COPD
Igor Barjaktarevic, MD, PhD, discusses the evolving treatment landscape in COPD, highlighting current treatment approaches and novel therapies on the horizon.
- What are the shortcomings of the current treatment approaches and what are novel therapies on the horizon?
- Some patients continue to have exacerbation despite triple therapy.
- Current therapies do not address type 2 inflammation.
